
Jan 16 (Reuters) - Arbutus Biopharma Corp ABUS.O:
ARBUTUS BIOPHARMA CORP - EPO REVOKES ARBUTUS BIOPHARMA'S EUROPEAN PATENT EP 2279254 - SEC FILING
ARBUTUS BIOPHARMA CORP - DECISION LIKELY TO AFFECT ARBUTUS CASE AGAINST MODERNA IN SWITZERLAND - SEC FILING
ARBUTUS BIOPHARMA CORP - EXPECTS NO IMPACT ON U.S., JAPAN, CANADA LITIGATION - SEC FILING
ARBUTUS BIOPHARMA CORP: CO DISAGREES WITH OUTCOME, PLANS TO FILE PETITION FOR REVIEW BY ENLARGED BOARD OF APPEAL OF EPO